Condition: Aortic Valve Stenosis · Aortic Stenosis · Aortic Valve Disease · Sponsor: EmStop Inc
The objective of this study is to demonstrate safety and efficacy of the EmStop Embolic Protection System when used as indicated to capture and remove thrombus/debris during self-expanding transcatheter aortic valve replacement (TAVR) procedures.
This description comes directly from the study's public registry record.
Katherine Vo · 763-227-9954 · k.vo@emstopeps.com
Danielle Gustasfon · 612-345-4544 · danielle.gustafson@brightresearch.com
Always discuss trial participation with your own doctor first.
| Ochsner Medical Center | New Orleans, Louisiana, United States | Recruiting |
| Mission Health | Asheville, North Carolina, United States | Recruiting |
| Monument Health Heart and Vascular Institute | Rapid City, South Dakota, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07276711